News
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
joined ABC News Live to discuss the promising results from Eli Lilly's newly announced weight loss pill. Drug maker Eli Lilly says data from a late-stage trial showed a reduction in weight of ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results